A Cohort Establishment Study of Total Management of Ovarian Cancer

University of Electronic Science and Technology of China (UESTC)

Status: Enrolling

Conditions: Tumor of Female Reproductive System; Ovarian Cancer

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT06018935

LCATM202304

Details and patient eligibility

About

A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).

Full description

1. To investigate the effects of surgery, chemotherapy, maintenance therapy and related factors on the prognosis and quality of life of patients with ovarian cancer (including fallopian tube cancer and primary peritoneal cancer);
2. To study the postoperative recovery of patients with ovarian cancer (including fallopian tube cancer and primary peritoneal cancer), perioperative complications, adverse reactions after chemotherapy, adverse reactions during targeted drug maintenance therapy, and explore possible effective preventive measures;
3. The prognostic factors of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer) were analyzed;
4. To study the efficacy and safety of PARPi in clinical application in patients with ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).

Enrollment: 500 estimated patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital;
2. Can cooperate with later follow-up.

Exclusion criteria

1. Patients with other malignant tumors or previous history of other malignant tumors;
2. Have cognitive impairment.